← Dashboard
Stock
AHG
Akso Health GroupLatest close $1.731 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
1
27 funds tracked
Ever held
2
Current + past
New this quarter
0
Exited this quarter
0
Marquee-fund ownership over time
Aug 9, 2024Aug 14, 2024Feb 14, 2025Aug 14, 2025
Now
1
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $0.95 | $1.73 | +82% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Millennium Management 2× in & out | Q1 2025 | Q3 2025 | → $1.74 | +34% |
Fundamentals
XBRL · Akso Health GroupAnnual figures sourced directly from Akso Health Group's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$14.78M
FY2025+500%+ YoY
Net income
-$134.98M
FY2025-500%+ YoY
EPS (diluted)
$-0.1600
FY2025-129% YoY
Free cash flow(?)
$1.18M
FY2025-13% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Akso Health Group — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 13, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 23, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERFeb 10, 2026
- 20-FANNUAL REPORTAug 14, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 1, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 28, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERNov 8, 2024
- 20-FANNUAL REPORTJul 30, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMay 2, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 26, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERMar 8, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJan 29, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJan 22, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERJan 3, 2024
- 6-KREPORT OF FOREIGN PRIVATE ISSUERNov 22, 2023
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Millennium Management | Q1 2025 | Q3 2025 | $1.30 | $1.74 | +34% |
| Millennium Management | Q3 2024 | Q4 2024 | $1.01 | $1.19 | +18% |
| Renaissance Technologies | Q3 2024 | open | $0.95 | $1.73 | +82% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.